Back to Newsroom
Back to Newsroom

Spago Nanomedical Publishes the Annual Report for 2021

Wednesday, 23 February 2022 04:50 AM

Spago Nanomedical

Topic:
Earnings

LUND, SWEDEN / ACCESSWIRE / February 23, 2022 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)

Spago Nanomedical's annual report for 2021 is from today available at the company's website, www.spagonanomedical.se.

For further information, please contact Mats Hansen, CEO Spago Nanomedical AB, +46 46 811 88, [email protected].

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of solid tumors. Spago Nanomedical´s share is listed on Nasdaq First North Growth Market (ticker: SPAGO). For further information, see www.spagonanomedical.se.

FNCA Sweden AB is the Certified Adviser of the company, +46 8 528 00 399, [email protected].

Attachments

Annual report 2021

SOURCE: Spago Nanomedical

Topic:
Earnings
Back to newsroom
Back to Newsroom

Contact Us Today


If you have questions or want to learn more about our products, our team’s here to help!

Share by: